Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,081-7,092 of 10,612

Other study type icon

CompletedNCT01867411

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalFrom 18 Years to 60 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT04412824

Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: Auburn University
Condition: Addiction

Drug study icon

CompletedNCT00893581

Multimodal Neuroimaging of Treatment Effects in Adolescent Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: University of Cincinnati
Condition: Bipolarity

Behavioral study icon

CompletedNCT04518943

Multiphase Optimization study of Incentives for Veterans to Encourage Walking

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 50 Years to 69 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression

Drug study icon

CompletedNCT06965569

Multiple Ascending Dose Phase 1 Study of ALA-3000

This study is completed in the United States. It focuses on Depression.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Alar Pharmaceuticals Inc.
Condition: Depression

Drug study icon

CompletedNCT01677377

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

This study is completed in the United States. It focuses on Schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT06025396

Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 59 Years

Countries: United States
Sponsor: Tempero Bio, Inc.
Condition: Addiction

Drug study icon

CompletedNCT02504476

Safety study of AMG 581 in schizophrenia

This study is completed in the United States. It is testing AMG 581 for schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Amgen
Condition: Schizophrenia

Drug study icon

CompletedNCT02332798

Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Biogen
Condition: Schizophrenia

Drug study icon

CompletedNCT00876304

Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Taisho Pharmaceutical Co., Ltd.
Condition: Schizophrenia

Drug study icon

CompletedNCT00795730

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 99 Years

Countries: United States
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT02044094

Blockade of Opioid Effects by Injections of Buprenorphine for Addiction

This study is completed in the United States. It is testing blockade of Opioid Effects by Injections of Buprenorphine for Addiction.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.